Skip to main content

Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong

Buy Article:

Your trusted access to this article has expired.

$34.78 + tax (Refund Policy)

OBJECTIVE: To identify risk factors for defaulting from anti-tuberculosis treatment.

SETTING: Directly observed treatment in Hong Kong Government chest clinics.

DESIGN: Defaulters were recruited from a cohort of tuberculosis patients registered from 1 January to 31 March 1999. Three controls per case, matched for age and sex, were selected randomly from the cohort. Patient factors, initial tuberculosis characteristics and treatment-related variables were collected by review of medical records.

RESULTS: On matching 102 defaulters and 306 controls, a logistic risk model of default that considered patient factors, initial disease characteristics and treatment-related factors identified seven risk factors: current smoking (OR 3.00, 95%CI 1.41–6.39), past TB with default (OR 6.23, 95%CI 1.95–19.91), poor initial adherence (OR 117.21, 95%CI 13.52–1015.92), fair initial adherence (OR 11.02, 95%CI 2.15–56.43), unknown initial adherence (OR 6.59, 95%CI 3.47–12.49), treatment side effects (OR 13.30, 95%CI 3.23–54.79), and subsequent hospitalisation (OR 0.27, 95%CI 0.11–0.67). Its predictive power was 85%. Another model that considered only factors on registration for treatment gave a lower predictive power of 70%.

CONCLUSIONS: Treatment default could be predicted fairly accurately by considering patient and treatment-related factors.

Keywords: adherence; treatment; tuberculosis

Document Type: Regular Paper

Affiliations: TB and Chest Service, Department of Health, Hong Kong

Publication date: 01 December 2004

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content